Lionel D’Hondt

Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma

Bart Neyns, Jan Sadones, E. Joosens et al. · Annals of Oncology · 2009 · 240 citations · Full text

Medicine, Oncology, Pharmacology +14

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

Robert J. Motzer, Camillo Porta, Masatoshi Eto et al. · Journal of Clinical Oncology · 2024 · 158 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

Emmanuel Seront, Sylvie Rottey, Brieuc Sautois et al. · Annals of Oncology · 2012 · 124 citations · Full text

Medicine, Oncology, Pharmacology +14

Oral mucositis induced by anticancer treatments: physiopathology and treatments

Lionel D’Hondt, Christophe Lonchay, Marc Andr� et al. · Therapeutics and Clinical Risk Management · 2006 · 89 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Prospective Randomized Study Comparing Docetaxel, Estramustine, and Prednisone With Docetaxel and Prednisone in Metastatic Hormone-Refractory Prostate Cancer

Jean‐Pascal Machiels, F Mazzeo, Marylène Clausse et al. · Journal of Clinical Oncology · 2008 · 87 citations · Full text

Medicine, Oncology, Pharmacology +15